Paper7538697
CD1 recognition by mouse NK1+ T lymphocytes.
Bendelac A and 5 others. Science, 1995. Cited by 768 papers, by iCite.
Cite this record
ConductScience Library. CD1 recognition by mouse NK1+ T lymphocytes. Papers, record 7538697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7538697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Antigens | |
| Antigens, CD1 | |
| Antigens, Surface | |
| Cell Line | |
| Humans | |
| Hybridomas | |
| Interleukin-4 | |
| Lectins, C-Type | |
| Ligands | |
| Mice | |
| Mice, Inbred C57BL | |
| NK Cell Lectin-Like Receptor Subfamily B | |
| Proteins | |
| Receptors, Antigen, T-Cell, alpha-beta |
Source PubMed
Cited by322
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 768 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42629952 | The Role of the T Cell Receptor Sequence in Shaping T Cell Functional Fate. | Immunol Rev | 2026 | https://conductscience.org/library/papers/42629952 | PubMed |
| 42183670 | CAR-iNKT cells for cancer therapy: a comprehensive review of engineering, mechanisms, and clinical progress. | Immunotherapy | 2026 | https://conductscience.org/library/papers/42183670 | PubMed |
| 41941497 | Pigs lacking Natural Killer T cells have altered cellular responses to influenza. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41941497 | PubMed |
| 41904478 | Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41904478 | PubMed |
| 41279250 | Pigs lacking Natural Killer T cells have altered cellular responses to influenza. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279250 | PubMed |
| 41116010 | Dual regulatory role of natural killer T cells during development of hepatocellular carcinoma. | Commun Biol | 2025 | https://conductscience.org/library/papers/41116010 | PubMed |
| 41000376 | Innate iNKT cells: from biological insight to clinical impact. | Front Immunol | 2025 | https://conductscience.org/library/papers/41000376 | PubMed |
| 40698085 | Global trends and frontiers in iNKT cells: a bibliometric and visualized analysis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40698085 | PubMed |
| 40305288 | Single-cell transcriptomic profiling reveals diversity in human iNKT cells across hematologic tissues. | Cell Rep | 2025 | https://conductscience.org/library/papers/40305288 | PubMed |
| 40121031 | PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40121031 | PubMed |
| 40102596 | CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma. | Br J Cancer | 2025 | https://conductscience.org/library/papers/40102596 | PubMed |
| 40019476 | Blocking the innate immune CD1d/NKT cell axis prevents the development of cortical hyperexcitability and posttraumatic epilepsy. | Epilepsia | 2025 | https://conductscience.org/library/papers/40019476 | PubMed |
| 39963129 | CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma. | Front Immunol | 2025 | https://conductscience.org/library/papers/39963129 | PubMed |
| 39917293 | Editorial: Cognate recognition, functional properties and immunotherapeutic applications of iNKT cells: leveling the road to the clinic. | Front Immunol | 2025 | https://conductscience.org/library/papers/39917293 | PubMed |
| 39561929 | Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells. | Clin Immunol | 2024 | https://conductscience.org/library/papers/39561929 | PubMed |
| 39280627 | Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy. | iScience | 2024 | https://conductscience.org/library/papers/39280627 | PubMed |
| 39224603 | Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39224603 | PubMed |
| 39170618 | Traversing the bench to bedside journey for iNKT cell therapies. | Front Immunol | 2024 | https://conductscience.org/library/papers/39170618 | PubMed |
| 38885470 | NKT Cells and Other Innate T Cells: The Immune Cells That Do Not Follow the Rules. | J Immunol | 2024 | https://conductscience.org/library/papers/38885470 | PubMed |
| 38863694 | Glycolipid antigen recognition by invariant natural killer T cells and its role in homeostasis and antimicrobial responses. | Front Immunol | 2024 | https://conductscience.org/library/papers/38863694 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD1B | 910 | PubTator's text mining | https://conductscience.org/library/genes/910 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7538697
GET https://conductscience.org/api/papers/v1/7538697/cited_by?page=2